540 related articles for article (PubMed ID: 6352020)
21. [Acute lymphoblastic leukemia of standard risk: preliminary results obtained with protocol LL-IV-81].
Verdeguer Miralles A; Castel Sánchez V; Ferris Tortajada J; Esquembre Menor C
An Esp Pediatr; 1987 Nov; 27(5):325-30. PubMed ID: 3481521
[TBL] [Abstract][Full Text] [Related]
22. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
Matsuzaki A; Ishii E; Okamura J; Eguchi H; Yoshida N; Yanai F; Inoue T; Miyake K; Ishihara T; Tsuboi C
Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
[TBL] [Abstract][Full Text] [Related]
23. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia.
Sackmann Muriel F; Svarch E; Pavlovsky S; Bustelo P; Giuntoli J; Vergara B; Garay G; Eppinger-Helft M; Kvicala R; Dibar E
Cancer Treat Rep; 1984 Apr; 68(4):581-6. PubMed ID: 6370428
[TBL] [Abstract][Full Text] [Related]
24. [Clinical trial of protocol-AL851 for children with high-risk acute lymphoblastic leukemia. Kyushu Yamaguchi Children's Cancer Study Group (KYCCSG)].
Matsuzaki A; Ishii E; Ueda K; Yanai F; Nibu K; Take H; Koga H; Miyazaki S; Inoue T; Miyake K
Rinsho Ketsueki; 1994 Sep; 35(9):862-70. PubMed ID: 7967055
[TBL] [Abstract][Full Text] [Related]
25. [End results and comparative analysis of treatment programs for childhood acute lymphocytic leukemia].
Kawai S; Fujimoto T
Gan To Kagaku Ryoho; 1987 Jan; 14(1):17-26. PubMed ID: 3467655
[TBL] [Abstract][Full Text] [Related]
26. [Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group].
Kawai S; Fujimoto T; Zha Z; Asami K; Oka T; Kaneko Y; Takaue Y; Ninomiya T; Nishikawa K; Tsuchiya T
Rinsho Ketsueki; 1993 Feb; 34(2):128-36. PubMed ID: 8492409
[TBL] [Abstract][Full Text] [Related]
27. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
[TBL] [Abstract][Full Text] [Related]
28. Combination chemotherapy in relapsed childhood acute lymphoblastic leukemia.
Amato KR; Sallan SE; Lipton JM
Cancer Treat Rep; 1984 Feb; 68(2):411-2. PubMed ID: 6583001
[TBL] [Abstract][Full Text] [Related]
29. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.
Ortega JA; Nesbit ME; Donaldson MH; Hittle RE; Weiner J; Karon M; Hammond D
Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412
[TBL] [Abstract][Full Text] [Related]
30. Sanctuary therapy: a randomized trial of 724 children with previously untreated acute lymphoblastic leukemia: A Report from Children's Cancer Study Group.
Nesbit ME; Sather H; Robison LL; Donaldson M; Littman P; Ortega JA; Hammond GD
Cancer Res; 1982 Feb; 42(2):674-80. PubMed ID: 7034927
[TBL] [Abstract][Full Text] [Related]
31. Prospective study of central nervous system changes in children with acute lymphoblastic leukemia receiving two different methods of central nervous system prophylaxis.
Ochs J; Parvey LS; Mulhern R
Neurotoxicology; 1986; 7(2):217-26. PubMed ID: 2431364
[No Abstract] [Full Text] [Related]
32. Intermediate dose methotrexate (IDM) in children with acute lymphocytic leukemia (ALL). An update.
Freeman AI
Sangre (Barc); 1985; 30(6):1007-33. PubMed ID: 3913034
[No Abstract] [Full Text] [Related]
33. Long-term relapse-free survival in adult acute lymphoblastic leukemia.
Gingrich RD; Burns CP; Armitage JO; Aunan SB; Edwards RW; Dick FR; Maguire LC; Leimert JT
Cancer Treat Rep; 1985 Feb; 69(2):153-60. PubMed ID: 3855697
[TBL] [Abstract][Full Text] [Related]
34. Treatment of acute lymphoblastic leukaemia.
Jacquillat C; Weil M; Gemon-Auclerc MF; Boiran M; Bernard J
Haematologia (Budap); 1976; 10(1):57-65. PubMed ID: 1070468
[TBL] [Abstract][Full Text] [Related]
35. Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (B.C.G.), intermittent methotrexate, and no therapy after a five-month intensive cytotoxic regimen ((Concord trial). Preliminary report to the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood.
Br Med J; 1971 Oct; 4(5781):189-94. PubMed ID: 4940157
[TBL] [Abstract][Full Text] [Related]
36. "Preventive" cranial irradiation in acute lymphoblastic leukemia in childhood.
von Lieven H; Heinze HG; Lampert F
Strahlentherapie; 1976 Jan; 151(1):3-9. PubMed ID: 1062866
[TBL] [Abstract][Full Text] [Related]
37. [Importance of anthracyclines in infants in the treatment of acute lymphoblastic and non-lymphoblastic leukemias].
Leverger G; Bancillon A; Schaison G
Pathol Biol (Paris); 1987 Jan; 35(1):87-90. PubMed ID: 3550617
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of high and low risk acute lymphoblastic leukemias in the child, with 2 modalities of preventive therapy on the central nervous system (Pethema 7/78 protocol)].
Ortega Aramburu JJ; Javier G; Montagut JM; Torán N
An Esp Pediatr; 1985 Nov; 23(6):417-30. PubMed ID: 3867301
[TBL] [Abstract][Full Text] [Related]
39. Development of an effective treatment program for childhood acute lymphocytic leukemia: a preliminary report.
Furman L; Camitta BM; Jaffe N; Sallan SE; Cassady JR; Traggis D; Leavitt P; Nathan DG; Frei E
Med Pediatr Oncol; 1976; 2(2):157-66. PubMed ID: 822270
[TBL] [Abstract][Full Text] [Related]
40. CNS prophylaxis using a triple intrathecal drug therapy without cranial irradiation in acute lymphoblastic leukaemia.
Asfour I; Misset JL; Mathe G; Sabbour MS
Int J Clin Pharmacol Res; 1988; 8(1):47-54. PubMed ID: 3163327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
